Literature DB >> 3382762

Influence of the menstrual cycle on the concentrations of estrogen and progesterone receptors in primary breast cancer biopsies.

C M Smyth1, D E Benn, T S Reeve.   

Abstract

There is controversy in the literature regarding the effects of endogenous hormones on estrogen receptors (ER) and progesterone receptors (PR) in young women with breast cancer. We studied 117 young women with primary breast cancer and assessed their breast biopsies for ER and PR. The women had a record of their last menstrual period prior to breast biopsy. The menstrual cycle was divided into four phases--early proliferative (days 1-7), late proliferative (days 8-15), early secretory (days 16-22), and late secretory (days 23-30). There were lower levels of both ER and PR in biopsies excised during the early secretory phase than in other phases of the cycle; early proliferative phase receptor positive medians of ER = 77 fmol/mg protein and PR = 467 fmol/mg protein fell to ER = 28 fmol/mg and PR = 128 fmol/mg protein in the early secretory phase.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3382762     DOI: 10.1007/bf01807557

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  16 in total

1.  Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer: a European multicenter study.

Authors:  G Leclercq; H Bojar; J Goussard; R I Nicholson; M F Pichon; A Piffanelli; A Pousette; S Thorpe; M Lonsdorfer
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

Review 2.  Therapeutic significance of sex-steroid hormone receptors in the treatment of breast cancer.

Authors:  G Leclercq; J C Heuson
Journal:  Eur J Cancer       Date:  1977-11       Impact factor: 9.162

Review 3.  Steroid hormone receptors in breast cancer treatment strategy.

Authors:  W L McGuire
Journal:  Recent Prog Horm Res       Date:  1980

4.  Comparison of an estrogen receptor related protein, the ERD5 antigen, with estrogen and progesterone receptors in breast cancer patients.

Authors:  C M Smyth; D E Benn; T S Reeve
Journal:  Pathology       Date:  1987-07       Impact factor: 5.306

5.  Relationship of age and menopausal status to estrogen receptor content in primary carcinoma of the breast.

Authors:  K S McCarty; J S Silva; E B Cox; G S Leight; S A Wells; K S McCarty
Journal:  Ann Surg       Date:  1983-02       Impact factor: 12.969

6.  Relation of estrogen and/or progesterone receptor content of breast cancer to patient outcome following adjuvant chemotherapy.

Authors:  B Fisher; C K Redmond; D L Wickerham; H E Rockette; A Brown; J Allegra; D Bowman; D Plotkin; J Wolter
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

7.  Prognostic factors in primary breast cancer.

Authors:  G M Clark; W L McGuire
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

8.  Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values.

Authors:  C Rose; S M Thorpe; K W Andersen; B V Pedersen; H T Mouridsen; M Blichert-Toft; B B Rasmussen
Journal:  Lancet       Date:  1985-01-05       Impact factor: 79.321

9.  Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer.

Authors:  G M Clark; C K Osborne; W L McGuire
Journal:  J Clin Oncol       Date:  1984-10       Impact factor: 44.544

10.  Variations in estrogen and progesterone receptor content in premenopausal breast cancer patients throughout the menstrual cycle.

Authors:  D Coradini; V Cappelletti; P Miodini; E Ronchi; G Scavone; G Di Fronzo
Journal:  Tumori       Date:  1984-08-31
View more
  4 in total

Review 1.  William L. McGuire Memorial Symposium. Estrogen and progestin effects in human breast carcinogenesis.

Authors:  R J King
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

2.  Different methylation of oestrogen receptor DNA in human breast carcinomas with and without oestrogen receptor.

Authors:  R Piva; A P Rimondi; S Hanau; I Maestri; A Alvisi; V L Kumar; L del Senno
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

3.  Prognostic effect of timing of operation in relation to menstrual phase of breast cancer patient--fact or fallacy.

Authors:  K Holli; J Isola; M Hakama
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

4.  Influence of tamoxifen-medroxyprogesterone sequential therapy on estrogen and progesterone receptor contents of breast cancer.

Authors:  S Noguchi; H Yamamoto; H Inaji; S Imaoka; H Koyama
Journal:  Jpn J Cancer Res       Date:  1989-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.